MedTrace Logo

A Prospective Radiostereometric Analysis (RSA) and Clinical Evaluation of the Triathlon Tritanium Total Knee Replacement

NCT02373761 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2015-02-27

No results posted yet for this study

Summary

This study seeks to find out if the tibial and patellar components of the Stryker Triathlon Tritanium primary total knee replacement achieve adequate fixation to the underlying bone.

Conditions

  • Osteoarthritis of the Knee

Interventions

DEVICE

Stryker Triathlon Tritanium primary knee

Sponsors & Collaborators

  • Stryker Orthopaedics

    collaborator INDUSTRY

  • Scott Sporer

    lead OTHER

Principal Investigators

  • Scott Sporer, MD · Central DuPage Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2019-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02373761 on ClinicalTrials.gov